Selected research
Industry Research
Microneedle-mediated Drug Delivery Patch Industry Research Report 2026
Market perspective
The global Microneedle-mediated Drug Delivery Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Microneedle-mediated Drug Delivery Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Microneedle-mediated Drug Delivery Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Microneedle-mediated Drug Delivery Patch include KINDEVA, Zosano Pharma, Vaxxas, Valeritas, TheraJect, Inc, Nitto, Nanopass Technologies, Microdermics and Lohmann Therapie-Systeme AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Microneedle-mediated Drug Delivery Patch market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microneedle-mediated Drug Delivery Patch Market by Company
KINDEVA
Zosano Pharma
Vaxxas
Valeritas
TheraJect, Inc
Nitto
Nanopass Technologies
Microdermics
Lohmann Therapie-Systeme AG
Corium
Becton-Dickinson(BD)Technologies
Microneedle-mediated Drug Delivery Patch Segment by Type
Solid Microneedle Technology
Hollow Microneedle Technology
Dissolving Microneedles Technology
Microneedle-mediated Drug Delivery Patch Segment by Application
Hospital
Retail Pharmacy
Others
Microneedle-mediated Drug Delivery Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle-mediated Drug Delivery Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microneedle-mediated Drug Delivery Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle-mediated Drug Delivery Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Microneedle-mediated Drug Delivery Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Microneedle-mediated Drug Delivery Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Microneedle-mediated Drug Delivery Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Microneedle Technology
- Hollow Microneedle Technology
- Dissolving Microneedles Technology
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- KINDEVA
- Zosano Pharma
- Vaxxas
- Valeritas
- TheraJect, Inc
- Nitto
- Nanopass Technologies
- Microdermics
- Lohmann Therapie-Systeme AG
- Corium
- Becton-Dickinson(BD)Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Microneedle-mediated Drug Delivery Patch Market Size (2021-2032)
- 2.2.2 Global Microneedle-mediated Drug Delivery Patch Sales (2021-2032)
- 2.2.3 Global Microneedle-mediated Drug Delivery Patch Market Average Price (2021-2032)
- 2.3 Microneedle-mediated Drug Delivery Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Solid Microneedle Technology
- 2.3.3 Hollow Microneedle Technology
- 2.3.4 Dissolving Microneedles Technology
- 2.4 Microneedle-mediated Drug Delivery Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Retail Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Microneedle-mediated Drug Delivery Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Microneedle-mediated Drug Delivery Patch Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Microneedle-mediated Drug Delivery Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Microneedle-mediated Drug Delivery Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Microneedle-mediated Drug Delivery Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Microneedle-mediated Drug Delivery Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Microneedle-mediated Drug Delivery Patch, Product Type & Application
- 3.8 Global Manufacturers of Microneedle-mediated Drug Delivery Patch, Established Date
- 3.9 Global Microneedle-mediated Drug Delivery Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 KINDEVA
- 4.1.1 KINDEVA Company Information
- 4.1.2 KINDEVA Business Overview
- 4.1.3 KINDEVA Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 KINDEVA Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.1.5 KINDEVA Recent Developments
- 4.2 Zosano Pharma
- 4.2.1 Zosano Pharma Company Information
- 4.2.2 Zosano Pharma Business Overview
- 4.2.3 Zosano Pharma Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zosano Pharma Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.2.5 Zosano Pharma Recent Developments
- 4.3 Vaxxas
- 4.3.1 Vaxxas Company Information
- 4.3.2 Vaxxas Business Overview
- 4.3.3 Vaxxas Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vaxxas Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.3.5 Vaxxas Recent Developments
- 4.4 Valeritas
- 4.4.1 Valeritas Company Information
- 4.4.2 Valeritas Business Overview
- 4.4.3 Valeritas Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Valeritas Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.4.5 Valeritas Recent Developments
- 4.5 TheraJect, Inc
- 4.5.1 TheraJect, Inc Company Information
- 4.5.2 TheraJect, Inc Business Overview
- 4.5.3 TheraJect, Inc Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TheraJect, Inc Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.5.5 TheraJect, Inc Recent Developments
- 4.6 Nitto
- 4.6.1 Nitto Company Information
- 4.6.2 Nitto Business Overview
- 4.6.3 Nitto Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nitto Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.6.5 Nitto Recent Developments
- 4.7 Nanopass Technologies
- 4.7.1 Nanopass Technologies Company Information
- 4.7.2 Nanopass Technologies Business Overview
- 4.7.3 Nanopass Technologies Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nanopass Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.7.5 Nanopass Technologies Recent Developments
- 4.8 Microdermics
- 4.8.1 Microdermics Company Information
- 4.8.2 Microdermics Business Overview
- 4.8.3 Microdermics Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Microdermics Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.8.5 Microdermics Recent Developments
- 4.9 Lohmann Therapie-Systeme AG
- 4.9.1 Lohmann Therapie-Systeme AG Company Information
- 4.9.2 Lohmann Therapie-Systeme AG Business Overview
- 4.9.3 Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.9.5 Lohmann Therapie-Systeme AG Recent Developments
- 4.10 Corium
- 4.10.1 Corium Company Information
- 4.10.2 Corium Business Overview
- 4.10.3 Corium Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Corium Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.10.5 Corium Recent Developments
- 4.11 Becton-Dickinson(BD)Technologies
- 4.11.1 Becton-Dickinson(BD)Technologies Company Information
- 4.11.2 Becton-Dickinson(BD)Technologies Business Overview
- 4.11.3 Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio
- 4.11.5 Becton-Dickinson(BD)Technologies Recent Developments
5 Global Microneedle-mediated Drug Delivery Patch Market Scenario by Region
- 5.1 Global Microneedle-mediated Drug Delivery Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2021-2032
- 5.2.1 Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2021-2026
- 5.2.2 Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2027-2032
- 5.3 Global Microneedle-mediated Drug Delivery Patch Revenue by Region: 2021-2032
- 5.3.1 Global Microneedle-mediated Drug Delivery Patch Revenue by Region: 2021-2026
- 5.3.2 Global Microneedle-mediated Drug Delivery Patch Revenue by Region: 2027-2032
- 5.4 North America Microneedle-mediated Drug Delivery Patch Market Facts & Figures by Country
- 5.4.1 North America Microneedle-mediated Drug Delivery Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2032)
- 5.4.3 North America Microneedle-mediated Drug Delivery Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Microneedle-mediated Drug Delivery Patch Market Facts & Figures by Country
- 5.5.1 Europe Microneedle-mediated Drug Delivery Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2032)
- 5.5.3 Europe Microneedle-mediated Drug Delivery Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Microneedle-mediated Drug Delivery Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Microneedle-mediated Drug Delivery Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Microneedle-mediated Drug Delivery Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Microneedle-mediated Drug Delivery Patch Market Facts & Figures by Country
- 5.7.1 South America Microneedle-mediated Drug Delivery Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2032)
- 5.7.3 South America Microneedle-mediated Drug Delivery Patch Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Microneedle-mediated Drug Delivery Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Microneedle-mediated Drug Delivery Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Microneedle-mediated Drug Delivery Patch Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Microneedle-mediated Drug Delivery Patch Sales by Type (2021-2032)
- 6.1.1 Global Microneedle-mediated Drug Delivery Patch Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Microneedle-mediated Drug Delivery Patch Revenue by Type (2021-2032)
- 6.2.1 Global Microneedle-mediated Drug Delivery Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Microneedle-mediated Drug Delivery Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Microneedle-mediated Drug Delivery Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Microneedle-mediated Drug Delivery Patch Sales by Application (2021-2032)
- 7.1.1 Global Microneedle-mediated Drug Delivery Patch Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Microneedle-mediated Drug Delivery Patch Revenue by Application (2021-2032)
- 7.2.1 Global Microneedle-mediated Drug Delivery Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Microneedle-mediated Drug Delivery Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Microneedle-mediated Drug Delivery Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Microneedle-mediated Drug Delivery Patch Value Chain Analysis
- 8.1.1 Microneedle-mediated Drug Delivery Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Microneedle-mediated Drug Delivery Patch Production Mode & Process
- 8.2 Microneedle-mediated Drug Delivery Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Microneedle-mediated Drug Delivery Patch Distributors
- 8.2.3 Microneedle-mediated Drug Delivery Patch Customers
9 Global Microneedle-mediated Drug Delivery Patch Analyzing Market Dynamics
- 9.1 Microneedle-mediated Drug Delivery Patch Industry Trends
- 9.2 Microneedle-mediated Drug Delivery Patch Industry Drivers
- 9.3 Microneedle-mediated Drug Delivery Patch Industry Opportunities and Challenges
- 9.4 Microneedle-mediated Drug Delivery Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst